Laboratory Corp. Is Maintained at Overweight by Morgan Stanley
Morgan Stanley Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $270
BofA Securities Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $271
Labcorp Holdings Analyst Ratings
Jefferies Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $275
Baird Maintains Labcorp Holdings(LH.US) With Buy Rating, Cuts Target Price to $286
Baird Adjusts Price Target on Labcorp to $286 From $289, Keeps Outperform Rating
Evercore Maintains Labcorp Holdings(LH.US) With Hold Rating, Maintains Target Price $260
Mizuho Securities Maintains Labcorp Holdings(LH.US) With Buy Rating, Announces Target Price $264
Barclays Maintains Labcorp Holdings(LH.US) With Hold Rating, Maintains Target Price $249
Labcorp Holdings Analyst Ratings
HSBC Upgrades Labcorp Holdings(LH.US) to Buy Rating
Piper Sandler Maintains Labcorp Holdings(LH.US) With Hold Rating, Raises Target Price to $240
Barclays Adjusts Price Target on Labcorp to $249 From $234, Maintains Equalweight Rating
BofA Securities Maintains Labcorp Holdings(LH.US) With Buy Rating, Announces Target Price $262
Evercore Maintains Labcorp Holdings(LH.US) With Hold Rating, Raises Target Price to $260
A Quick Look at Today's Ratings for Labcorp Holdings(LH.US), With a Forecast Between $249 to $289
Evercore ISI Sticks to Its Hold Rating for Laboratory (LH)
Laboratory Corp. Is Maintained at Outperform by Baird
Labcorp Holdings Analyst Ratings